CORT
CORT
NASDAQ · Pharmaceuticals

Corcept Therapeutics Inc

Mid-Cap Stocks Pharmaceutical Stocks Healthcare Stocks
$71.63
-7.59 (-9.58%)
As of Nov 5, 9:55 PM ET ·
CORT News2 articles
Everpure Surges 2.2% After S&P 500 Inclusion, Adding $723M
Everpure (P) gains 2.2% after hours on S&P 500 promotion, adding $723M. Q2 revenue up 38% but free cash flow turns negative. Index inclusion effective Sept. 21.
Markets
Corcept Shares Leap 27% on Strong Lifyorli Launch and Upbeat Guidance
Corcept Therapeutics shares jumped 27.4% after Q2 revenue rose 32% to $256.1M, driven by Lifyorli sales of $47.6M. The company lifted its 2026 revenue outlook to $1.1-1.2 billion.
Earnings